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Chronic itch development in sensory neurons
requires BRAF signaling pathways
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Chronic itch, or pruritus, is associated with a wide range of skin abnormalities. The mechanisms responsible for
chronic itch induction and persistence remain unclear. We developed a mouse model in which a constitutively
active form of the serine/threonine kinase BRAF was expressed in neurons gated by the sodium channel Nav1.8
(BRAFNav1.8 mice). We found that constitutive BRAF pathway activation in BRAFNav1.8 mice results in ectopic
and enhanced expression of a cohort of itch-sensing genes, including gastrin-releasing peptide (GRP) and
MAS-related GPCR member A3 (MRGPRA3), in nociceptors expressing transient receptor potential vanilloid 1
(TRPV1). BRAFNav1.8 mice showed de novo neuronal responsiveness to pruritogens, enhanced pruriceptor excitability, and heightened evoked and spontaneous scratching behavior. GRP receptor expression was increased
in the spinal cord, indicating augmented coding capacity for itch subsequent to amplified pruriceptive inputs.
Enhanced GRP expression and sustained ERK phosphorylation were observed in sensory neurons of mice with
allergic contact dermatitis– or dry skin–elicited itch; however, spinal ERK activation was not required for maintaining central sensitization of itch. Inhibition of either BRAF or GRP signaling attenuated itch sensation in
chronic itch mouse models. These data uncover RAF/MEK/ERK signaling as a key regulator that confers a
subset of nociceptors with pruriceptive properties to initiate and maintain long-lasting itch sensation.
Introduction
The ability of the brain to discriminate pain from itch in order
to make binary decisions — eliciting either withdrawal or
scratching behavior — is critically dependent on the functional
connectivity of the somatosensory system. Itch information,
along with pain, is conveyed by primary afferents of the dorsal root ganglion (DRG) to the spinal cord and of the trigeminal ganglion neurons to the trigeminal subnucleus caudalis
of the brainstem, respectively, which in turn supplies input
to the somatosensory cortex through spinothalamic tract or
trigeminothalamic tract neurons (1–4). At the molecular level,
emerging evidence suggests that activation of GPCRs in sensory neurons is likely responsible for relaying distinct types of
acute stimulus-evoked itch (5–7). In addition, several transient
receptor potential (TRP) channels, including TRP vanilloid 1
(TRPV1) and TRPA1, have been implicated in mediating histaminergic and nonhistaminergic itch, respectively (8–10). In the
spinal cord, gastrin-releasing peptide (GRP) receptor (GRPR)
and neurons expressing GRPR are key mediators dedicated to
the coding of itch sensation (11–13). In contrast to acute itch,
chronic itch may arise from an altered or diseased state of the
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skin or immune or nervous systems or from a dysregulation
of metabolism. Chronic itch represents a significant clinical
problem, largely due to its resistance to most commonly used
antihistamine-based therapies (14, 15). To date, little is known
about signaling mechanisms underlying chronic itch in the nervous system. At the cellular level, mice lacking the transcription
factor Bhlhb5 in a subset of spinal cord cells showed a heightened
itch transmission, presumably resulting from a loss of inhibitory interneurons expressing Bhlhb5 during development (16).
In contrast, mice lacking spinal GRPR+ neurons lack the ability
to sense chronic itch (13). In sensory neurons, the conditional
deletion of vesicular glutamate transporter 2 (Vglut2) results in
spontaneous itch sensation (17, 18), and TRPA1 is important for
dry skin itch (19). Ablation of neurons expressing MAS-related
GPCR member A3 (MRGPRA) attenuates dry skin and allergic
itch, suggesting that MRGPRA3+ neurons are also important
for the development of chronic itch (20). Although GRPR has
emerged as an important receptor for mediating acute itch, the
function of GRPR and its cognate ligand GRP in chronic itch
has not been characterized.
BRAF is a serine/threonine kinase that activates ERK, a member of the MAPKs superfamily, through the RAF/MEK/ERK
cascade. Upon activation, pERK triggers the expression of a
plethora of transcription factors in the nucleus to regulate a
wide array of cellular functions (21, 22). Our previous studies
of conditional BRAF loss-of-function mice have uncovered an
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Figure 1
Increased levels of pMEK1/2 and pERK1/2 in sensory neurons and aberrant innervations in the spinal cords of BRAFNav1.8 mice. (A) A representative Western blot and (B) quantified data show increased levels of pMEK1/2 and pERK1/2 but unchanged total MEK1/2 and ERK1/2 levels in
DRGs of BRAFNav1.8 mice. n = 6 per genotype. All the lanes were run on the same gel but are noncontiguous. *P < 0.05, **P < 0.01, BRAFNav1.8
mice vs. wild-type. (C–F) Increased pERK+ cells are indicated by double staining with pERK (red) and IB4 (green) or with pERK (brown) in
Trpv1+ (blue) cells in BRAFNav1.8 mice compared to wild-type mice. n = 4 per genotype. ***P < 0.001. (G–L) Expression of molecular markers with
IB4 (green) in DRGs of wild-type and BRAFNav1.8 mice. (M) Quantitative comparison of DRG neurons between 2 groups. n = 3 per genotype.
(N–P) Expression of (N) CGRP and (O) IB4 in the spinal cords of wild-type and BRAF Nav1.8 mice. Arrows and arrowheads indicate
(C and E) pERK+ or pERK– cells, respectively, and (G–L) IB4+ or IB4– cells, respectively. Scale bar: 20 μm.

essential role for RAF signaling in the extension of peripheral
sensory projections as well as in the initial development of some
of the DRG’s molecular makeup and central projections (23).
To further explore potential roles of BRAF signaling in sensory
transduction, we generated BRAFNav1.8 mice in which the BRAF
kinase is selectively activated in sensory neurons expressing the
sodium channel Nav1.8 by genetically replacing the wild-type
Braf gene with a kinase-activated one in these neurons (24, 25).
BRAF Nav1.8 mice exhibited spontaneous scratching behavior,
prompting us to hypothesize that BRAF signaling plays a role in
pruriceptive transmission.
4770

Results
Peptidergic and nonpeptidergic fibers maintain their cellular identity
but show aberrant central projections in BRAFNav1.8 mice. The mutant
V600EBRAF protein was strongly expressed in DRG neurons of
BRAFNav1.8 mice (Supplemental Figure 1; supplemental material
available online with this article; doi:10.1172/JCI70528DS1), and,
as expected, the levels of phosphorylated MEK1/2 and ERK1/2
(pMEK1/2 and pERK1/2) were significantly elevated in DRG neurons of BRAFNav1.8 mice relative to those of wild-type mice (Figure 1,
A and B). Total BRAF and CRAF expression levels did not differ in DRG neurons between BRAFNav1.8 and wild-type mice
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Figure 2
BRAFNav1.8 mice showed excessive spontaneous scratching and
significantly enhanced pruritogen-evoked scratching. (A) BRAFNav1.8
mice developed age-dependent spontaneous scratching behavior
from 6 to 14 weeks. n = 6 to 8 per each time point. (B) BRAFNav1.8 mice
developed skin lesions (arrows). (C) Prior to development of spontaneous scratching (at 4~6 weeks of age), BRAFNav1.8 mice showed
significantly enhanced scratching responses to pruritogens injected
into the nape (CQ; histamine [His]; compound 48/80 [48/80]; endothelin-1 [ET-1]) or to GRP injected i.t. Saline was the vehicle control.
*P < 0.05, ***P < 0.001, BRAFNav1.8 compared to WT littermates in the
same test, BRAFNav1.8 vs. wild-type. n = 5–9.

(Supplemental Figure 1). In wild-type mice, pERK+ neurons were
sparse in DRGs (3.2%), but they were widespread in DRG neurons of BRAFNav1.8 mice (30.9%) (Figure 1, C and D). The number
of pERK+ cells increased similarly in DRG neurons at cervical,
thoracic, and lumbar segmental levels (Supplemental Figure 2).
The density of primary afferent fibers innervating in cervical and
lumbar back hairy skin regions also increased in BRAFNav1.8 mice
(Supplemental Figure 3). Ectopic pERK was detected in neurons
expressing lectin-binding IB4 (a nonpeptidergic marker) and
TRPV1, both commonly used markers for subsets of nociceptors (26). The proportion of TRPV1+ neurons expressing pERK
increased from 5.0% to 35.1% (Figure 1, E and F). In contrast,
the proportions of neurons expressing NeuN (neuronal-specific
nuclear protein, a neuronal marker), NF200 (a large-diameter
and myelinated neuronal marker), peripherin (a small-diameter
neuronal marker), CGRP, IB4, TRPV1, and P2X3 (a pain-sensing
ATP-gated ion channel also expressed in IB4+ cells) were comparable between the 2 groups (Figure 1, G–M). Thus, the fates of peptidergic, nonpeptidergic, and large-diameter neurons were maintained in BRAFNav1.8 mice.
Peptidergic and nonpeptidergic fibers innervate laminae I and
II outer layer (IIo) and lamina II inner layer (IIi) in the spinal cord,
respectively (Figure 1, N–P). In BRAF Nav1.8 mice, CGRP+ fibers
expanded to lamina IIi and were colocalized with IB4, whereas
the nonpeptidergic IB4+ fibers invaded laminae I and IIo domains
(Figure 1, N–P). These findings reveal that an appropriate level of
BRAF signaling is important in directing the segregation of peptidergic and nonpeptidergic primary afferents to their respective
target zones of the spinal cord.
Spontaneous and enhanced evoked scratching behavior of BRAFNav1.8
mice. At around 6 weeks of age, about 50% of BRAFNav1.8 mice
showed spontaneous scratching behavior, followed by skin lesions
(Figure 2, A and B, and Supplemental Video 1). By 2 months of age,
the majority of BRAFNav1.8 mice had visible skin lesions, most notably around the craniofacial areas (Figure 2B) and the neck region.
Prior to the onset of spontaneous scratching, BRAF Nav1.8 mice
demonstrated a markedly enhanced scratching response to nape

intradermal (i.d.) injection of a number of pruritogens, including
chloroquine (CQ), a nonhistaminergic pruritogen mediated in part
through MRGPRA3 (27), histamine, compound 48/80, and endothelin-1 (Figure 2C). Scratching behavior elicited by intrathecal
(i.t.) injection of GRP was also significantly enhanced (Figure 2C),
suggesting augmented GRPR signaling. Therefore, both histaminergic and nonhistaminergic itch were significantly enhanced, indicating increased pruriceptive transmission from the periphery to
the spinal cords of BRAFNav1.8 mice. To assess whether BRAF activation alters nociceptive processing, we carried out a series of pain
behavioral tests prior to the onset of the spontaneous scratching.
The responses of BRAFNav1.8 mice to either noxious or nonnoxious
mechanical stimuli were normal (Supplemental Figure 4, A and B)
as was acute thermal sensitivity (Supplemental Figure 4, C and D).
In addition, BRAFNav1.8 mice exhibited normal licking and flinching responses to intraplantar injection of noxious chemicals such
as formalin and mustard oil (Supplemental Figure 4, E and F).
Thermal and mechanical hypersensitivity induced by intraplantar
injection of capsaicin and complete Freund’s adjuvant was also
normal (Supplemental Figure 5, A–D). Moreover, BRAFNav1.8 mice
exhibited normal motor function prior to the onset of excessive
scratching behavior (Supplemental Figure 5E).
Massive ectopic expression of GRP/GRPR signaling in BRAFNav1.8 mice.
The enhanced itch behavior prompted us to assess the expression
of GRP in DRG neurons of BRAFNav1.8 mice. The number of GRP+
cells nearly doubled in BRAFNav1.8 mice (13.5%) compared with
that in wild-type mice (7.2%) (Figure 3, A–C). Consistent with the
observation of little variability in pERK+ staining in DRGs or skin
regions at different levels (Supplemental Figures 2 and 3), the
percentage of GRP+ cells detected was similar at different spinal
segmental levels (Supplemental Figure 6). The proportion of cells
expressing Mrgpra3, as detected by in situ hybridization (ISH),
increased strikingly from 5.2% to 19.0% (Figure 3, D–F). The percentage of cells expressing histamine 1 receptor (H1R), a key receptor implicated in mediating histaminergic itch (28), increased
from 12.7% to 20.0% (Figure 3, G–I). The ectopic expression of
GRP, Mrgpra3, and H1R was found predominantly in TRPV1+ cells
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Figure 3
Ectopic expression of itch mediators in BRAFNav1.8 mice. (A–I) BRAFNav1.8 mice showed ectopic expression of (A–C) GRP, (D–F) Mrgpra3, and
(G–I) H1R in DRGs. (J–R) BRAFNav1.8 mice showed increased expression of (M–O) Mrgpra3 (blue) but not (J–L) GRP (brown) and (P–R) H1R
(brown) in Trpv1+ cells (blue in J–L and P–R; brown in M–O). (S–X) Enhanced expression of GRPR as shown by (S–U) GFP staining and (V–X)
Grpr mRNA in the dorsal horns of BRAFNav1.8 mice. (Y–AA) Enhanced GRP in primary afferents of BRAFNav1.8 mice. All mice were 8~12 weeks of
age, except in V–AA, where 2-week-old mice were used. Scale bar: 20 μm. (J–Q) Arrows and arrowheads indicate TRPV1+ and TRPV1– neurons,
respectively. *P < 0.05, **P < 0.01, ***P < 0.001, BRAFNav1.8 mice vs. wild-type. n = 4.

but also in TRPV1– cells (Figure 3, J–R); this was verified by their
double staining with Trpv1 ISH (Figure 3, J–L and P–R) or TRPV1
antibody staining (Figure 3, M–O).
We next examined coexpression of Mrgpra3 with other markers
in DRG neurons. The proportion of pERK/Mrgpra3-coexpressing
cells was not significantly increased in BRAFNav1.8 mice (Supplemental Figure 7, A, B, and J). In wild-type mice, Mrgpra3 was mainly
expressed in P2X3+/peripherin+/NF200–/CGRP– cells (Supplemental Figure 7J). In BRAFNav1.8 DRG, despite the overall marked
increase of Mrgpra3+ cells, the expression pattern of Mrgpra3 in
P2X3+/peripherin+/NF200–/CGRP– cells was unchanged. However,
the proportion of Mrgpra3+ cells coexpressing CGRP+, H1R+, and
GRP+ significantly increased (Supplemental Figure 7J). Moreover,
the numbers of cells coexpressing Mrgpra3 with pERK, NF200,
peripherin, P2X3, GRP, CGRP, and H1R all markedly increased
in BRAFNav1.8 mice (Supplemental Figure 7K), indicating that
4772

Mrgpra3 was ectopically expressed in several major types of DRG
neurons, including both TRPV1+ and TRPV1– cells (Figure 3N),
and most prominently in GRP+ cells (Supplemental Figure 7K).
To examine GRPR expression, we took advantage of GRPR-EGFP
mice that allow the detection of GRPR+ neurons by anti-GFP staining. As expected, GFP expression was primarily restricted to lamina I of the spinal cords of GRPR-EGFP mice (Figure 3S), but its
expression expanded entirely into lamina II of the spinal cords in
GRPR-EGFP/BRAFNav1.8 mice (Figure 3T). This expression was validated by similar Grpr mRNA expansion detected by ISH (Figure 3,
V and W). Consistently, GRP+ fibers were much more abundant
and expanded into entire lamina II in BRAFNav1.8 mice (Figure 3,
Y–AA), matching the marked increase of GRP in DRG neurons
(Figure 3, A–C). Notably, we did not observe an upregulation of
GRP immunostaining intrinsic to dorsal horn interneurons of
BRAFNav1.8 mice relative to the control (Figure 3, Y–AA).
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Figure 4
Enhanced and de novo responses to CQ and histamine but
not to capsaicin in DRG cells from BRAFNav1.8 mice. (A and B)
Three representative traces of DRG cells from (A) wildtype or (B) BRAFNav1.8 mice responsive to CQ (100 μM),
histamine (50 μM), and capsaicin (Cap; 1 μM). (B) Note that
one CQ-responsive cell tested also responded to histamine
and capsaicin. (C) The percentage of CQ-responsive DRG
cells, but not histamine- and capsaicin-responsive cells, was
significantly increased in BRAFNav1.8 mice. More DRG cells
responded to both CQ and histamine in BRAFNav1.8 mice
than in wild-type mice. (D) Of all capsaicin-sensitive cells in
BRAFNav1.8 mice, there was a significant increase of cells that
responded to CQ or to both CQ and histamine, whereas no
difference was detected in the percentage of cells responsive
to both capsaicin and histamine. (E and F) Venn diagrams
showing the relative proportions of DRG cells of (E) wild-type
mice and (F) BRAFNav1.8 mice responsive to CQ, histamine,
and capsaicin. *P < 0.05, **P < 0.01, BRAFNav1.8 vs. wild-type.
n = 4 (a total of 1,161 cells were tested).

Increased percentage of DRG neurons responding to CQ and histamine.
We next analyzed the response of dissociated DRG neurons to
CQ and histamine using calcium imaging. The percentage of cells
responsive to CQ significantly increased in BRAFNav1.8 neurons
(8.5% wild-type vs. 19.4% BRAFNav1.8), whereas that of histamineresponsive cells increased without statistical significance (10.6%
wild-type vs. 13.1% BRAFNav1.8) (Figure 4, A–C). Few wild-type cells
responded to both CQ and histamine, whereas there were significantly more cells responsive to both in BRAFNav1.8 neurons (1.6%
wild-type vs. 6.1% BRAFNav1.8) (Figure 4, A–C, E, and F). Of capsaicinresponsive cells, the percentage of cells responsive to CQ (7.9%
wild-type vs. 25.1% BRAFNav1.8) or to both CQ and histamine (3.8%
wild-type vs. 15.2% BRAFNav1.8) increased significantly (Figure 4,
D–F). Taken together, these data provide physiological evidence
supporting de novo responsiveness of BRAFNav1.8 DRG neurons to
pruritogens but not to capsaicin.
Increased excitability of DRG neurons in response to histamine and CQ.
We next measured basic electrophysiological parameters of dissociated DRG neurons using current clamp recording. Among
cells ranging in size from 17.5 to 32.5 μm, 3 firing patterns were
observed: single spike (SS), delayed, and tonic firing (Figure 5, A–C,
and Supplemental Table 1). Overall, SS cells showed a larger diameter, more hyperpolarized resting membrane potential, decreased
input resistance, and higher rheobase values than delayed and
tonic firing cells (Supplemental Table 1). Interestingly, the percentage of SS cells was much smaller in BRAFNav1.8 mice compared
with that in wild-type mice (36.3% wild-type vs. 16.3% BRAFNav1.8),
whereas the percentage of tonic firing cells almost doubled in

BRAFNav1.8 mice (25.0% wild-type vs. 47.5% BRAFNav1.8) (Supplemental Table 1). The number of delayed firing cells remained the
same (Supplemental Table 1). For either wild-type or BRAFNav1.8
mice, the cells responsive to pruritogens were typically tonic firing
cells, which were readily excitable (Figure 5, D, E, G, and H). Only
on rare occasion did SS cells respond to pruritogens. The tonic firing population of cells in BRAFNav1.8 mice exhibited a small increase
in soma diameter, whereas SS neurons showed a smaller rheobase
value relative to that of the control (Supplemental Table 1).
The percentage of small-diameter cells responsive to histamine
and CQ increased substantially in BRAFNav1.8 mice (Figure 5,
F and I). Despite this expansion, the response magnitudes, in terms
of firing frequency in response to histamine or CQ, were largely
the same (Figure 5, D, E, G, and H). Thus, there was a dramatic
expansion of tonic firing cells at the expense of SS cells in tandem
with increased expression of itch mediators. These changes might
underlie the enhanced and spontaneous itch in BRAFNav1.8 mice.
Attenuated itch sensation of BRAFNav1.8 mice by a blockade of histaminergic and GRP/GRPR signaling. To distinguish whether incessant
scratching behavior was a result of aberrant projection of primary
afferents or ectopic expression of itch mediators, we generated
Grp–/– mice (Figure 6, A–C). Consistent with our previous observations (27), neither DRG neurons nor the spinal cords showed
GRP staining in Grp–/– mice (Figure 6, D–G). A recent study
claimed that GRP immunostaining is largely attributable to neurons intrinsic to the dorsal spinal cord (29). To clarify this, we
repeated the dorsal rhizotomy experiment (12). As expected, on the
ipsilateral side almost all CGRP+ fiber staining in the dorsal horn
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Figure 5
Electrophysiological characterization of DRG cells from BRAFNav1.8 mice and wild-type mice. (A–C) The BRAFNav1.8 DRG cells exhibited altered
distribution of firing properties. In both BRAFNav1.8 mutant and wild-type cells, 3 firing patterns were routinely observed as (A) SS, (B) delayed,
and (C) tonic. (D, E, G, and H) Representative action potential firing patterns of wild-type and BRAFNav1.8 cells in response to (D and E) CQ and
(G and H) histamine. The cells responding to pruritogens typically exhibited tonic firing properties with low rheobase values. Response magnitude
was generally similar between wild-type and BRAFNav1.8 mice. (F and I) Venn diagrams of total DRG cells showing that the percentage changes
of DRG cells responsive to (F) CQ and (I) histamine substantially increased in BRAFNav1.8 mice relative to wild-type mice. (F) CQ (1 mM) induced
action potential firing in 3 out of 44 (6.8%) wild-type DRG cells and in 8 out of 61 (13.1%) mutant DRG cells. (I) Histamine (100 μM) induced action
potential firing in 7 out of 44 (15.9%) wild-type DRG cells and in 14 out of 61 (23.0%) mutant DRG cells.

was lost, confirming the success of dorsal rhizotomy (Figure 6,
H–J and P). Similarly, GRP+ immunostaining was nearly abolished
on the ipsilateral side of the surgery but remained intact on the
contralateral side (Figure 6, K–P), confirming that the presence of
GRP+ immunostaining in the superficial dorsal horn was primary
afferents dependent. These results directly challenge a previous
study showing strong GRP staining in the spinal cord after the
dorsal root rhizotomy (29). Importantly, spontaneous scratching
of BRAFNav1.8 mice was markedly diminished in either Grp–/– or
Grpr KO mice and nearly abolished when GRPR+ neurons were
ablated with bombesin-saporin (Figure 7A and ref. 13). Scratching induced by i.t. GRP was also dramatically reduced after i.p.
injection of 77427, a small-molecule GRP blocker (ref. 30 and
Figure 7B). Neither Grp–/– nor Grpr KO mice showed an inhibitory
effect of 77427 on CQ-elicited scratching observed in wild-type
mice (Figure 7B), demonstrating the specificity of 77427 as a GRP
blocker and supporting the role of GRP as an itch neurotransmitter in acute and chronic itch. Consistently, i.p. injection of 77427
4774

significantly reduced spontaneous scratching in BRAFNav1.8 mice
(Figure 7C) as did chlorpheniramine, a histamine antagonist (28),
and U0126, a MEK inhibitor (31) (Figure 7C). U0126 failed to
attenuate scratching behavior elicited by CQ and histamine
(Figure 7D). Hence, these results demonstrate that ectopic ERK
activation and expression of GRP and H1R are responsible for the
spontaneous scratching of BRAFNav1.8 mice.
Mice with chronic itch induced by allergic contact dermatitis and dry
skin recapitulate ectopic ERK activation and expression of itch mediators
in BRAFNav1.8 mice. To assess the relevance of BRAF signaling to the
development of chronic itch, we used a mouse model of allergic contact dermatitis (ACD), a prevalent skin disease triggered by direct
skin contact with haptens or allergens, induced by topical application of a chemical hapten, 2, 4-dinitrofluorobenzene (DNFB)
(32). A hallmark of ACD is intractable chronic itch that is resistant to antihistamines (33, 34). DNFB induces a T cell–mediated
hypersensitivity reaction in human skin (35, 36) and similarly
initiates sensitization and elicitation phases in mice that manifest
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Figure 6
Generation of Grp –/– mice and
confirmation of GRP expression in primary sensory neurons.
(A) Targeting strategy for generation of Grp–/– mice. (B and C) Germ
line transmission was confirmed
by (B) Southern blot and (C) PCR
analysis. (D–G) GRP expression in the (D and E) DRGs and
(F and G) spinal cords of (D and F)
wild-type mice and (E and G)
Grp –/– mice. (H–O) Expression
of (H–J) CGRP and (K–O) GRP
in the lumbar spinal cords of
C57BL/6J mice 14 days after unilateral dorsal rhizotomy (L5). On
contralateral sides, both (H and I)
CGRP+ and (K, L, and N) GRP+
fibers were mainly in the superficial dorsal horn (lamina I, IIo);
but on the ipsilateral sides, both
(H and J) CGRP and (K, M, and
O) GRP staining was lost after unilateral L5 dorsal rhizotomy. Arrows
indicate the elimination of staining.
n = 3 per group. (P) Quantitation
of remaining CGRP+ (15.1%) and
GRP+ (10.2%) staining in the L5
superficial dorsal horn after rhizotomy. Boxed areas in L and M are
shown at higher magnification
in N and O. Scale bar: 10 μm
(D and E); 20 μm (F and G);
40 μm (H–O).

as spontaneous scratching behavior (ref. 37 and see below). DNFB
treatment resulted in thickening of epidermis, increased lymph
node and spleen size, increased number of neutrophils, infiltration
of inflammatory mast cells, and elevated serum IgE levels (Figure 8,
A–E). The number of white blood cells also increased, but the difference was not statistically significant (Figure 8C). Thymic stromal
lymphopoietin (TSLP), a marker for skin inflammation and dermatitis (38), also increased significantly (Figure 8F). Importantly,
DNFB-induced spontaneous scratching was significantly diminished by i.t. U0126 (Figure 9C). In mice treated with DNFB, ectopic
ERK activation and expression of GRP and Mrgpra3 were detected
in DRG neurons (Figure 9, D–L), and increased GRPR expression
was detected in the spinal cord (Figure 9, M–O).
Finally, we analyzed whether BRAF signaling may have a role in
itch induced by skin dryness (xerosis). Dry skin is caused by disrupting cutaneous barrier function and is associated with rough,
scaly, and flaky skin often accompanied by chronic pruritus (39).
Topical application of an acetone/ether mixture followed by water
leads to spontaneous scratching (Figure 9B), resulting from skin

stratum corneum dehydration and epidermal water loss, and dry
skin itch is mediated by histamine-independent mechanisms
(40, 41). Similarly, dry skin itch was attenuated by U0126 (Figure 9C).
Ectopic ERK activation and expression of GRP, Mrgpra3, and
GRPR were observed in DRG neurons of mice with dry skin itch
(Supplemental Figure 8). To assess whether spinal ERK activation
is required to maintain spontaneous itch, we examined ERK activation in the dorsal horns of mice 1 day after the last DNFB or
dry skin treatment. For a direct comparison of pERK activation to
central hypersensitivity, pERK staining after intraplantar capsaicin
injection (a model of inflammatory pain) was used as the control
(ref. 42 and Supplemental Figure 9). We did not detect pERK+
cells in the spinal cord, despite ongoing spontaneous itch in both
chronic itch models (Supplemental Figure 9), indicating that pERK
upregulation in DRG instead of the spinal cord is necessary and
sufficient for maintaining both peripheral and central sensitization. Interestingly, CGRP+ and IB4+ fibers projected normally in the
dorsal horns of mice with ACD and dry skin itch (Supplemental
Figure 10), unlike the expansion of peptidergic and nonpeptidergic
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Figure 7
Genetic and pharmacologic blockade of spontaneous scratching behavior in BRAFNav1.8 mice. (A) Spontaneous scratching of
BRAF Nav1.8 mice was significantly attenuated in Grp–/– or Grpr
KO background and in mice treated with i.t. bombesin-saporin
(BB-sap). *P < 0.05, **P < 0.01, 1-way ANOVA followed by posthoc analysis, wild-type vs. BRAFNav1.8 mice. (B) GRP blocker 77427
(i.p.) significantly reduced scratching elicited by GRP (i.t.) or CQ
(i.d.) in wild-type mice but not in Grp–/– or Grpr KO mice. (C) Spontaneous scratching of BRAFNav1.8 mice was significantly reduced
by i.p. injection of 77427 or the H1R antagonist chlorpheniramine
(CRP) or i.t. injection of a MEK inhibitor, U0126. (D) Scratching
behavior of mice induced by i.d. CQ and histamine did not differ
after i.t. U0126. *P < 0.05, **P < 0.01, 2-tailed t test vs. vehicle
controls. n = 6–10.

fibers seen in BRAFNav1.8 mice, indicating that the latter was due to
developmental changes and unlikely to contribute to the chronic
itch behavior phenotypes. Taken together, these results reveal that,
in mouse models of ACD and dry skin itch, ectopic ERK activation
and expression of GRP and Mrgpra3 occurred similarly to that in
BRAFNav1.8 mice and suggest that pERK and GRP/GRPR signaling
are critical for the progression and maintenance of long-lasting itch
transmission (Figure 9P).
Discussion
Here, we identify the BRAF pathway as an upstream regulator of
expression of a cohort of itch mediators in mouse sensory neurons. Our data further demonstrate that GRP/GRPR signaling
plays an important role in the initiation and maintenance of
long-lasting itch in 3 distinct genetic and/or clinically relevant
chronic itch models. Finally, our data suggest that a phenotypic
switch from nociceptors to pruriceptors underlies the transition
from acute itch signaling to pathological itch state.
BRAFNav1.8 mice are a new and unique genetic model for unraveling how pruriceptive transmission is progressively enhanced at the
molecular and circuit levels, as increasing scratching behavior correlates well with an expression profile change of itch mediators. The
fact that enhanced evoked scratching preceded the manifestation
of spontaneous itch (from 3 weeks of age to around 6 weeks of age)
suggests the existence of a postnatal period for developmental maturation of itch circuitry as well as a threshold for the intensity of
ongoing itch signaling. We cannot exclude the possibility that skin
lesion or inflammation resulting from excessive scratching might
have contributed to further increase of scratching as mice age.
Interestingly, we have observed more pERK+ fiber innervation in
the skin. Coupled with increased GRP+ fiber innervation in skin of
mice with atopic dermatitis (43), it will be interesting to see whether
the interactions between skin lesion/inflammation and enhanced
itch-specific nerve innervation are part of positive feedback
mechanisms that are engaged to provoke more itching signaling
4776

and exacerbate scratching response. In both ACD and dry skin
models, similar progressively increased scratching responses were
observed, albeit in a much shorter period, suggesting that skin sensitization/inflammation may account for at least some aspects of
peripheral and central sensitization of itch signaling.
Because the total number of sensory neurons remained unaltered, the finding that substantial de novo expression of GRP
and Mrgpra3 primarily concentrated in TRPV1+ neurons implies
that a small subset of nociceptors has acquired novel pruriceptive
properties. Similar de novo neuronal responsiveness to pruritogens has been observed in mice with dry skin (41). Our finding
that a population of tonic firing sensory neurons was significantly expanded at the expense of SS cells indicates that some
nociceptors switched from unresponsive to responsive or excitable
to pruritogenic stimuli. We refer to cells that express in situ
itch mediators as “primary pruriceptors,” which form the basal
circuits for acute itch transmission, while cells expressing de novo
itch mediators are “secondary pruriceptors.” Mechanistically, we
suggest that a recruitment of secondary pruriceptors is a prerequisite for initiating and sustaining prolonged pruriceptive transmission. This phenotypic switch mechanism may also underlie
central sensitization of itch in the context of chronic itch.
Our studies reveal that enhanced and persistent expression of
GRP in sensory neurons is necessary for transmitting itch-specific
information to the spinal cord in chronic itch states. A sustained
release of GRP may necessitate additional GRPR signaling or the
secondary itch neurons, so that the capacity of the central itch
circuit is expanded to accommodate the amplified itch signaling
to the brain. It remains unclear, however, which subpopulation of
dorsal horn neurons is capable of expressing de novo GRPR. The
present study confirms the specificity of the anti-GRP antibody
(27, 29) as well as primary afferents as the source of GRP protein
in the superficial dorsal horn, which was first demonstrated in rats
(44). While it has been known that Grp mRNA is expressed in the
dorsal horn (45, 46), importantly, chronic itch did not upregulate
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Figure 8
Analysis of skin and immune system in adult mice with ACD.
(A) H&E and toluidine blue staining of the neck skin of the
mice with ACD and the control mice. The mice with ACD
showed epidermal hyperplasia, hyperkeratosis, acanthosis,
dermal inflammation, and mast cell infiltration (insets show
a few mast cells). Scale bar: 25 μm. (B and C) The systemic
manifestations of allergic dermatitis were presented as highlighted by their (B) enlarged spleen and lymph nodes and
(C) significantly increased blood neutrophil counts. SPL,
spleen. Scale bar: 4 mm. (D) Quantitative analysis confirmed that ACD enhanced the extent of mast cell infiltration
in the dermis. Mast cells in 9 random ×200 microscope fields
were counted and averaged. (E) IgE levels were highly elevated in mice with ACD. (F) Tslp mRNA was overexpressed
in the ACD skin. Representative RT-PCR images (bottom).
*P < 0.05, **P < 0.01, ***P < 0.001, mice with ACD vs. the
controls (acetone only). n = 6.

GRP protein in spinal interneurons. The corroborative evidence,
therefore, led us to conclude that spinal Grp mRNA does not
equate to GRP protein expression. Failure to detect Grp mRNA
in DRG neurons by ISH or lack of EGFP in DRGs of GRP-EGFP
transgenic mice highlights the technical limitations that have
resulted in differing interpretation (29, 47).
Complementary to our loss-of-function studies (12, 13), the finding that a dramatic upregulation of GRP/GRPR signaling failed to
impact both acute and chronic pain behavior of BRAFNav1.8 mice
in a profound manner reinforces the idea that GRP/GRPR signaling represents a dedicated molecular labeled line for itch from
periphery to the spinal cord. This is in contrast to B-type natriuretic
peptide (BNP), which has recently been proposed to be dedicated
to activation of its receptor natriuretic peptide receptor-A (NPRA)
for itch transmission from DRGs to the spinal cord (47). However,
BNP-NPRA–mediated autoregulation in DRG neurons was also
implicated in nociceptive processing in DRG neurons (48). Indeed,
we found that i.t. injection of BNP also regulated inflammatory
pain behavior (Zhao et al., unpublished observations).
BRAFNav1.8 mice enable us to position BRAF signaling upstream
of key itch effectors in sensory neurons of mice with chronic itch.
Notably, unlike DRG neurons, pERK activation in the spinal cords
of mice with ACD and dry skin occurred only transiently after
skin was acutely sensitized and was absent the following day when
spontaneous scratching was persistent. This suggests that pERK
activation in the spinal cord is dispensable for maintaining central sensitization of itch. Nonetheless, the capability of the BRAF
signaling cascade to regulate expression of a wide range of itch
mediators from histaminergic itch to nonhistaminergic itch genes
reveals a remarkable molecular and cellular specificity as well as
plasticity intrinsic to sensory neurons.
ERK signaling was differentially activated in nociceptors in
response to varying noxious stimuli (49, 50). While it is unclear
why pruriceptive genes are selectively activated, our analyses of

ACD and dry skin models suggest that different types of persistent pruriceptive stimuli may differentially trigger pERK signaling in different subsets of pruriceptors. For example, although
ERK was activated, no upregulation of H1R was observed in ACD
or dry skin models. Moreover, despite ERK activation and ectopic
expression of GRP in DRG neurons and GRPR in the spinal
cord, the temporal and spatial patterns of spontaneous scratching between these chronic itch models differ dramatically. Thus,
behavioral output encoded by the sustained ERK activation in
sensory neurons may be dictated by the nature of a pruriceptive
stimulus as well as the state of itch or pain sensitization. A combinatorial activation of itch mediators and types of neurons in
which they are activated is manifest in the duration, intensity,
and regional patterns of itch response, the last of which is also
inherently restrained by the areas in which a mouse can reach and
scratch using its hind limbs.
How is ERK signaling triggered upon acute contact dermatitis
or dry skin induction? A host of extracellular stimuli can
activate ERK signaling (21, 22, 51), making it possible that heightened levels of such factors in the extracellular milieu as a result
of local metabolic dysregulation or inflammation can stimulate
intracellular BRAF to augment itch signaling. Considering the
progressive development of chronic itch, it is possible that these
factors may also activate a diverse group of GPCRs, which in
turn initiates the RAF/MEK/ERK cascade (21, 52). As a result, an
amplified BRAF signal may further sensitize itch circuits through
a positive feedback loop via GPCR-dependent integration of
downstream ERK signaling. Identification of ERK-dependent
transcriptional events would be a logical next step to link
extracellular stimuli to the expression of downstream effector genes
that encode itch information. Finally, the present study supports
the role of GRP as an itch-specific neuropeptide in sensory neurons,
in agreement with previous findings that GRP was upregulated in primary afferents of primates with chronic itch (53) and in patients (54).
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Figure 9
Mice with ACD- and dry skin–induced itch recapitulate the phenotype of BRAFNav1.8 mice. (A) Mice with ACD induced by DNFB exhibited progressively increased scratching behavior. Red arrows indicate the time points when DNFB was applied, and spontaneous scratches were counted
24 hours afterward. n = 7. (B) Progressively increased scratching behavior was induced in mice with dry skin itch. n = 13. (C) Spontaneous scratching
of mice with ACD or dry skin was significantly reduced by i.t. U0126. n = 5~9 per group. *P < 0.05, **P < 0.01, mice treated with U0126 vs. the controls. (D–F) Ectopic activation of ERK and (G–I) expression of GRP. (J–L) Mrgpra3 in DRGs and (M–O) GRPR as shown by GFP staining (E, H,
K, and N) in the dorsal horns of mice with ACD compared to (D, G, J, and M) the controls (acetone only). In M–O, GRPR-EGFP mice were used.
Results in F, I, L, and O are quantitative comparisons between 2 groups (n = 3 per group). Scale bar: 10 μm (D, E, G, and H); 20 μm (J, K, M, and N).
(P) Diagram illustrates BRAF/MEK/ERK regulation of itch molecular phenotype in DRG. *P < 0.05, ***P < 0.001, mice with ACD vs. the controls.

We suggest that an upregulation of GRP/GRPR represents a hallmark of the development of chronic itch. A repertoire of pharmacologic inhibitors of the BRAF cascade in clinical trials for patients
with cancer (55) may be used in combination with inhibitors of
GRP or GRPR to provide a more effective strategy for ameliorating
chronic itch conditions than either type of inhibitor alone.
Methods
Additional details regarding this study are provided in the Supplemental
Methods.
Mice. Mice with a floxed allele for BrafV600E (V600Ef/WT mice) (24) were
crossed with Nav1.8Cre/+ mice (25) to generate mice with specific expression of
BrafV600E in Nav1.8+ cells (referred to herein as BRAFNav1.8 mice). Littermates
4778

harboring the genotypes Nav1.8WT/WT with BrafV600E, Nav1.8Cre/WT with
BrafWT/WT, and Nav1.8WT/WT with BrafWT/WT were used as controls. Generation
of Grpr KO mice and GRPR-EGFP mice was described previously (12, 56, 57).
For generation of Grp–/– mice, see the Supplemental Methods.
Behavioral studies. The motor, itch, and pain behavioral studies were
performed as described previously (12, 13). Chronic itch models were
used as described previously (40, 58).
Immunohistochemistry and ISH. Standard procedures were used as
described previously (59).
RT-PCR and Western blot analysis. RT-PCR and Western blot analysis were
carried out as described previously (11).
Calcium imaging and electrophysiology. Dissociated DRG neurons were loaded
with fura 2-acetoxymethyl ester (Invitrogen) and imaged at 340 and 380 nm
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excitation to detect intracellular-free calcium for analysis of the relative proportions of DRG neurons responsive to pruritogens. Current clamp recordings were acquired on dissociated DRG neurons as described previously (60).
Skin and immune system in mice with ACD. Back neck skin and blood samples
were harvested from mice for various analyses as described previously (61).
Statistics. Behavioral tests, cell counting, or molecular analysis were performed by observers blinded to the treatments and/or genotypes of the
animals used. Unless indicated otherwise, cervical DRGs and dorsal horns
were used. All quantification data are presented as mean ± SEM, and error
bars represent SEM. Statistical comparisons were performed with 1-way or
2-way ANOVA followed by post-hoc analysis, Student’s t test, or the χ2 test,
as specifically indicated in the figure legends. However, unless otherwise
indicated, the statistical analyses were done using t test, and P < 0.05 was
considered statistically significant.
Study approval. All experiments were performed in accordance with the
guidelines of the NIH and the International Association for the Study of
Pain and were approved by the Animal Studies Committee at Washington
University School of Medicine and the Institutional Animal Care and Use
Committees at Weill Cornell Medical College.
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